Loading…
Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells
Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immu...
Saved in:
Published in: | Cancer science 2022-06, Vol.113 (6), p.2179-2193 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23 |
container_end_page | 2193 |
container_issue | 6 |
container_start_page | 2179 |
container_title | Cancer science |
container_volume | 113 |
creator | Izumi, Aya Yamamoto, Koji Kawaguchi, Makiko Yamashita, Fumiki Fukushima, Tsuyoshi Kiwaki, Takumi Tanaka, Hiroyuki Yamashita, Yoshihiro Kataoka, Hiroaki |
description | Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression.
Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts. |
doi_str_mv | 10.1111/cas.15346 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9207362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A740914125</galeid><sourcerecordid>A740914125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23</originalsourceid><addsrcrecordid>eNp1ks1u1DAQxyMEoqVw4AVQJC5w2K2_Ym8uSKsVH5UqcQDO1sQ73rhK7MVOtsqNR-AZeRKcbikUgS3ZI89v_uMZTVE8p2RJ8zo3kJa04kI-KE4pF_VCESIf3thqURPOToonKV0RwqWoxePihFecM0nEaXG48Gm01hmH3kxlsGWLexiCmQYsdzFcD21pwQwhlvl0B5gt51vXuGz9-PadliZ4izGV3dTvWxicyf4DJBf8LDcEvxuxNBCN86GH0mDXpafFIwtdwme391nx5d3bz5sPi8uP7y8268uFyb-TC0YVAJdWCgW0URKQWiVFhVvOBAEqsQFktqoqaVc1Raug2a7qHLslK9Uwfla8Oerux6bHrUE_ROj0Proe4qQDOH3f412rd-Gga0YUl7PAq1uBGL6OmAbduzSXAB7DmDSTQhDGVrXI6Mu_0KswRp_Ly5RaMV4TKn9TO-hQO29DzmtmUb1WgtRUUFZlavkPKu8t9i43HK3L7_cCXh8DTAwpRbR3NVKi5yHReUj0zZBk9sWfTbkjf01FBs6PwHXOMv1fSW_Wn46SPwHejsgi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678239016</pqid></control><display><type>article</type><title>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Izumi, Aya ; Yamamoto, Koji ; Kawaguchi, Makiko ; Yamashita, Fumiki ; Fukushima, Tsuyoshi ; Kiwaki, Takumi ; Tanaka, Hiroyuki ; Yamashita, Yoshihiro ; Kataoka, Hiroaki</creator><creatorcontrib>Izumi, Aya ; Yamamoto, Koji ; Kawaguchi, Makiko ; Yamashita, Fumiki ; Fukushima, Tsuyoshi ; Kiwaki, Takumi ; Tanaka, Hiroyuki ; Yamashita, Yoshihiro ; Kataoka, Hiroaki</creatorcontrib><description>Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression.
Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts.</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/cas.15346</identifier><identifier>PMID: 35332604</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>c-Met protein ; Cell culture ; Cell surface ; CRISPR ; Fibroblasts ; Gene deletion ; Genomes ; Growth rate ; HAI‐1 ; Hepatocyte growth factor ; HGF ; Immunohistochemistry ; Immunoreactivity ; Kinases ; Lymphatic system ; matriptase ; Medical research ; Metastasis ; Oral cancer ; oral squamous cell carcinoma ; Original ; Plasmin ; Protease inhibitors ; Proteases ; Proteinase inhibitors ; Proteins ; R&D ; Research & development ; Serine proteinase ; Squamous cell carcinoma ; Surgery ; Tongue ; Tumor microenvironment ; Tumors ; U-Plasminogen activator ; Vascular endothelial growth factor ; VEGF‐C ; Xenografts</subject><ispartof>Cancer science, 2022-06, Vol.113 (6), p.2179-2193</ispartof><rights>2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>COPYRIGHT 2022 John Wiley & Sons, Inc.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23</cites><orcidid>0000-0002-9350-777X ; 0000-0001-9948-0451</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2678239016/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2678239016?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35332604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Izumi, Aya</creatorcontrib><creatorcontrib>Yamamoto, Koji</creatorcontrib><creatorcontrib>Kawaguchi, Makiko</creatorcontrib><creatorcontrib>Yamashita, Fumiki</creatorcontrib><creatorcontrib>Fukushima, Tsuyoshi</creatorcontrib><creatorcontrib>Kiwaki, Takumi</creatorcontrib><creatorcontrib>Tanaka, Hiroyuki</creatorcontrib><creatorcontrib>Yamashita, Yoshihiro</creatorcontrib><creatorcontrib>Kataoka, Hiroaki</creatorcontrib><title>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</title><title>Cancer science</title><addtitle>Cancer Sci</addtitle><description>Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression.
Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts.</description><subject>c-Met protein</subject><subject>Cell culture</subject><subject>Cell surface</subject><subject>CRISPR</subject><subject>Fibroblasts</subject><subject>Gene deletion</subject><subject>Genomes</subject><subject>Growth rate</subject><subject>HAI‐1</subject><subject>Hepatocyte growth factor</subject><subject>HGF</subject><subject>Immunohistochemistry</subject><subject>Immunoreactivity</subject><subject>Kinases</subject><subject>Lymphatic system</subject><subject>matriptase</subject><subject>Medical research</subject><subject>Metastasis</subject><subject>Oral cancer</subject><subject>oral squamous cell carcinoma</subject><subject>Original</subject><subject>Plasmin</subject><subject>Protease inhibitors</subject><subject>Proteases</subject><subject>Proteinase inhibitors</subject><subject>Proteins</subject><subject>R&D</subject><subject>Research & development</subject><subject>Serine proteinase</subject><subject>Squamous cell carcinoma</subject><subject>Surgery</subject><subject>Tongue</subject><subject>Tumor microenvironment</subject><subject>Tumors</subject><subject>U-Plasminogen activator</subject><subject>Vascular endothelial growth factor</subject><subject>VEGF‐C</subject><subject>Xenografts</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1ks1u1DAQxyMEoqVw4AVQJC5w2K2_Ym8uSKsVH5UqcQDO1sQ73rhK7MVOtsqNR-AZeRKcbikUgS3ZI89v_uMZTVE8p2RJ8zo3kJa04kI-KE4pF_VCESIf3thqURPOToonKV0RwqWoxePihFecM0nEaXG48Gm01hmH3kxlsGWLexiCmQYsdzFcD21pwQwhlvl0B5gt51vXuGz9-PadliZ4izGV3dTvWxicyf4DJBf8LDcEvxuxNBCN86GH0mDXpafFIwtdwme391nx5d3bz5sPi8uP7y8268uFyb-TC0YVAJdWCgW0URKQWiVFhVvOBAEqsQFktqoqaVc1Raug2a7qHLslK9Uwfla8Oerux6bHrUE_ROj0Proe4qQDOH3f412rd-Gga0YUl7PAq1uBGL6OmAbduzSXAB7DmDSTQhDGVrXI6Mu_0KswRp_Ly5RaMV4TKn9TO-hQO29DzmtmUb1WgtRUUFZlavkPKu8t9i43HK3L7_cCXh8DTAwpRbR3NVKi5yHReUj0zZBk9sWfTbkjf01FBs6PwHXOMv1fSW_Wn46SPwHejsgi</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Izumi, Aya</creator><creator>Yamamoto, Koji</creator><creator>Kawaguchi, Makiko</creator><creator>Yamashita, Fumiki</creator><creator>Fukushima, Tsuyoshi</creator><creator>Kiwaki, Takumi</creator><creator>Tanaka, Hiroyuki</creator><creator>Yamashita, Yoshihiro</creator><creator>Kataoka, Hiroaki</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9350-777X</orcidid><orcidid>https://orcid.org/0000-0001-9948-0451</orcidid></search><sort><creationdate>202206</creationdate><title>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</title><author>Izumi, Aya ; Yamamoto, Koji ; Kawaguchi, Makiko ; Yamashita, Fumiki ; Fukushima, Tsuyoshi ; Kiwaki, Takumi ; Tanaka, Hiroyuki ; Yamashita, Yoshihiro ; Kataoka, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>c-Met protein</topic><topic>Cell culture</topic><topic>Cell surface</topic><topic>CRISPR</topic><topic>Fibroblasts</topic><topic>Gene deletion</topic><topic>Genomes</topic><topic>Growth rate</topic><topic>HAI‐1</topic><topic>Hepatocyte growth factor</topic><topic>HGF</topic><topic>Immunohistochemistry</topic><topic>Immunoreactivity</topic><topic>Kinases</topic><topic>Lymphatic system</topic><topic>matriptase</topic><topic>Medical research</topic><topic>Metastasis</topic><topic>Oral cancer</topic><topic>oral squamous cell carcinoma</topic><topic>Original</topic><topic>Plasmin</topic><topic>Protease inhibitors</topic><topic>Proteases</topic><topic>Proteinase inhibitors</topic><topic>Proteins</topic><topic>R&D</topic><topic>Research & development</topic><topic>Serine proteinase</topic><topic>Squamous cell carcinoma</topic><topic>Surgery</topic><topic>Tongue</topic><topic>Tumor microenvironment</topic><topic>Tumors</topic><topic>U-Plasminogen activator</topic><topic>Vascular endothelial growth factor</topic><topic>VEGF‐C</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Izumi, Aya</creatorcontrib><creatorcontrib>Yamamoto, Koji</creatorcontrib><creatorcontrib>Kawaguchi, Makiko</creatorcontrib><creatorcontrib>Yamashita, Fumiki</creatorcontrib><creatorcontrib>Fukushima, Tsuyoshi</creatorcontrib><creatorcontrib>Kiwaki, Takumi</creatorcontrib><creatorcontrib>Tanaka, Hiroyuki</creatorcontrib><creatorcontrib>Yamashita, Yoshihiro</creatorcontrib><creatorcontrib>Kataoka, Hiroaki</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley-Blackwell Backfiles (Open access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Izumi, Aya</au><au>Yamamoto, Koji</au><au>Kawaguchi, Makiko</au><au>Yamashita, Fumiki</au><au>Fukushima, Tsuyoshi</au><au>Kiwaki, Takumi</au><au>Tanaka, Hiroyuki</au><au>Yamashita, Yoshihiro</au><au>Kataoka, Hiroaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</atitle><jtitle>Cancer science</jtitle><addtitle>Cancer Sci</addtitle><date>2022-06</date><risdate>2022</risdate><volume>113</volume><issue>6</issue><spage>2179</spage><epage>2193</epage><pages>2179-2193</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression.
Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>35332604</pmid><doi>10.1111/cas.15346</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-9350-777X</orcidid><orcidid>https://orcid.org/0000-0001-9948-0451</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-9032 |
ispartof | Cancer science, 2022-06, Vol.113 (6), p.2179-2193 |
issn | 1347-9032 1349-7006 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9207362 |
source | Publicly Available Content Database; Wiley Open Access; PubMed Central |
subjects | c-Met protein Cell culture Cell surface CRISPR Fibroblasts Gene deletion Genomes Growth rate HAI‐1 Hepatocyte growth factor HGF Immunohistochemistry Immunoreactivity Kinases Lymphatic system matriptase Medical research Metastasis Oral cancer oral squamous cell carcinoma Original Plasmin Protease inhibitors Proteases Proteinase inhibitors Proteins R&D Research & development Serine proteinase Squamous cell carcinoma Surgery Tongue Tumor microenvironment Tumors U-Plasminogen activator Vascular endothelial growth factor VEGF‐C Xenografts |
title | Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A14%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insufficiency%20of%20hepatocyte%20growth%20factor%20activator%20inhibitor%E2%80%901%20confers%20lymphatic%20invasion%20of%20tongue%20carcinoma%20cells&rft.jtitle=Cancer%20science&rft.au=Izumi,%20Aya&rft.date=2022-06&rft.volume=113&rft.issue=6&rft.spage=2179&rft.epage=2193&rft.pages=2179-2193&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/cas.15346&rft_dat=%3Cgale_pubme%3EA740914125%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2678239016&rft_id=info:pmid/35332604&rft_galeid=A740914125&rfr_iscdi=true |